$APM - Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma: https://finance.yahoo.com/news/aptorum-group-receives-fda-orphan-130000549.html
Top Gainer for 1-20-22: $APM
3 years ago by jktrades (45)